Janus Henderson Group PLC Sells 273,276 Shares of STERIS plc (NYSE:STE)

Janus Henderson Group PLC lowered its stake in STERIS plc (NYSE:STE) by 16.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,413,306 shares of the medical equipment provider’s stock after selling 273,276 shares during the period. Janus Henderson Group PLC owned 1.43% of STERIS worth $290,517,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the stock. Magnolia Capital Advisors LLC lifted its stake in STERIS by 1.9% in the fourth quarter. Magnolia Capital Advisors LLC now owns 2,534 shares of the medical equipment provider’s stock valued at $521,000 after buying an additional 48 shares during the last quarter. Park Edge Advisors LLC lifted its stake in STERIS by 1.1% in the fourth quarter. Park Edge Advisors LLC now owns 4,662 shares of the medical equipment provider’s stock valued at $958,000 after buying an additional 51 shares during the last quarter. Citizens Financial Group Inc. RI lifted its stake in STERIS by 5.9% in the fourth quarter. Citizens Financial Group Inc. RI now owns 975 shares of the medical equipment provider’s stock valued at $201,000 after buying an additional 54 shares during the last quarter. Opal Wealth Advisors LLC lifted its stake in STERIS by 5.7% in the fourth quarter. Opal Wealth Advisors LLC now owns 1,118 shares of the medical equipment provider’s stock valued at $230,000 after buying an additional 60 shares during the last quarter. Finally, Sage Private Wealth Group LLC lifted its stake in STERIS by 4.1% in the fourth quarter. Sage Private Wealth Group LLC now owns 1,537 shares of the medical equipment provider’s stock valued at $316,000 after buying an additional 61 shares during the last quarter. Institutional investors own 94.69% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently commented on STE. JMP Securities restated a “market outperform” rating and set a $265.00 price target on shares of STERIS in a research note on Thursday, April 10th. Stephens upgraded STERIS to a “strong-buy” rating in a research note on Thursday, May 1st. Needham & Company LLC restated a “hold” rating on shares of STERIS in a research note on Monday, April 7th. Finally, Piper Sandler upped their price target on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Buy” and an average price target of $258.75.

STERIS Trading Up 0.3%

NYSE:STE opened at $226.54 on Monday. The stock has a fifty day moving average price of $223.40 and a two-hundred day moving average price of $218.80. The stock has a market capitalization of $22.26 billion, a price-to-earnings ratio of 48.10 and a beta of 0.96. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. STERIS plc has a 1 year low of $200.98 and a 1 year high of $248.24.

STERIS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 26th. Shareholders of record on Tuesday, June 10th will be given a $0.57 dividend. This represents a $2.28 annualized dividend and a yield of 1.01%. The ex-dividend date is Tuesday, June 10th. STERIS’s payout ratio is 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.